SCHEMBL26302004

SCHEMBL26302004

CC(=O)c1ccn2c(C(C)=O)cc(-c3ccc(C(F)(F)F)cc3)c2c1

nearest known ligand 0.47

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ BAZ2B Q9UIF8 11/20 0.47
▸ BAZ2A Q9UIF9 11/20 0.47
▸ BACE1 P56817 1/20 0.41
▸ SCN5A Q14524 3/20 0.40
▸ SCN9A Q15858 3/20 0.40
▸ APP P05067 1/20 0.39
▸ MAOB P27338 1/20 0.39
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39
▸ KDM1A O60341 1/20 0.39
▸ BRD9 Q9H8M2 2/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ SMARCA2 P51531 1/20 0.38
▸ SMARCA4 P51532 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26300877 0.91 CYP2C8 (0.43) BAZ2BBAZ2ABACE1SCN5ASCN9A
SCHEMBL26300894 0.90 CYP2C8 (0.42) BAZ2BBAZ2ABACE1SCN5ASCN9A
SCHEMBL26301906 0.89 BAZ2B (0.49) BAZ2BBAZ2ABACE1APPAKR1C3
SCHEMBL26300978 0.88 BACE1 (0.47) BAZ2BBAZ2ABACE1APPMAOB
SCHEMBL26301924 0.87 BAZ2B (0.47) BAZ2BBAZ2AMAOBKDM1ABRD9
SCHEMBL26302021 0.86 BAZ2B (0.54) BAZ2BBAZ2ABRD9BRD4SMARCA2
SCHEMBL26300911 0.86 BACE1 (0.47) BAZ2BBAZ2ABACE1MAOBAKR1C3
SCHEMBL26300949 0.84 BAZ2B (0.51) BAZ2BBAZ2ABACE1SCN5ASCN9A
SCHEMBL26301092 0.84 PTPN11 (0.42) BAZ2BBAZ2ABACE1MAOBBRD9
SCHEMBL26302080 0.84 BAZ2B (0.67) BAZ2BBAZ2ABACE1APPBRD9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4233864-A1 INTERFERON GENE STIMULATOR COMPOSITION COMPRISING INDOLIZINE DERIVATIVE AS ACTIVE INGREDIENT Ajou University Industry-Academic Cooperation Foundation (KR) 2023-08-30 — — EP disclosed
Send feedback